Advertisement
Product › Details
QR-010 (ProQR Therapeutics)
Next higher product group | mRNA-based drug | |
Status | 2014-08-18 development pp existent | |
Organisation | ProQR Therapeutics B.V. | |
Today | ProQR Therapeutics N.V. (Nasdaq: PRQR) | |
Group | ProQR Therapeutics (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for mRNA-based drug
- [1] Pantherna Therapeutics GmbH / Wacker. (4/5/24). "Press Release: Pantherna and Wacker Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals". Munich & Hennigsdorf....
- [2] Caris Life Sciences Inc.. (10/24/23). "Press Release: Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology Therapeutics". Irving, TX....
- [3] BioNTech AG. (3/1/23). "Press Release: BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel". Jerusalem....
- [4] CureVac N.V.. (2/8/23). "Press Release: CureVac Announces Pricing of Upsized Public Offering of Common Shares". Tübingen & Boston, MA....
- [5] CureVac N.V.. (2/6/23). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA....
- [6] BioNTech SE. (2/2/23). "Press Release: BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility". Mainz....
- [7] BioNTech SE. (11/14/22). "Press Release: BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore". Mainz & Singapore....
- [8] BeiGene, Ltd.. (7/6/22). "Press Release: BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies". Cambridge, MA, Basel & Beijing....
- [9] Moderna, Inc.. (4/27/22). "Press Release: Arpa Garay Joins Moderna as Chief Commercial Officer". Cambridge, MA....
- [10] Pantherna Therapeutics GmbH. (1/11/22). "Press Release: Pantherna Therapeutics Secures EUR 4.0 Mio. Follow-on Financing to Advance Its Therapeutic mRNA Development Programs". Hennigsdorf....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top